USE OF FAAH INHIBITORS AS NEUROPROTECTIVE AGENTS IN THE CNS
摘要
<p>The present disclosure relates to methods of using a fatty acid amide hydrolase (FAAH) inhibitor of Formula I alone or in combination with one or more additional therapeutic agents for the treatment or prevention of neuronal injury or neurodegeneration in a patient in need thereof.</p>
